(July.27th-31th)
25. The National Health Commission of China issued the Administrative Measures for the Clinical Use of Oncology Drugs (Draft for Comment) on July 29 in order to strengthen the administration of the clinical use of medical institutions’ oncology drugs, improve the levels of rational clinical use of oncology drugs, standardize the behaviors of clinically using oncology drugs, and guarantee the medical quality and safety.

Read More:
Pharmaceutical News of the Week | CPhI.CN - Performance
About the Author:
Caicai, a Master of Pharmacy from Shanghai Jiaotong University, used to work in the Institute of Science and Technical Information. Currently as a practitioner in the drug surveillance system, she is good at interpreting industry regulations, pharmaceutical research developments, etc.
-----------------------------------------------------------------------
Editor's Note:
To become a freelance writer of PharmaSources.com,
Email: Julia.Zhang@imsinoexpo.com.










(All Rights Reserved)